e-learning
resources
Berlin 2001
Sunday 23.09.2001
Therapeutical strategies for acute respiratory failure in COPD patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
When to give corticosteroid inhalation therapy in stable COPD
F. Alkan, E. Tuncay, A. Gencoglu, G. Ortakoylu, A. Bahadir, E. Caglar (Yedikule, Istanbul, Turkey)
Source:
Annual Congress 2001 - Therapeutical strategies for acute respiratory failure in COPD patients
Session:
Therapeutical strategies for acute respiratory failure in COPD patients
Session type:
Thematic Poster Session
Number:
547
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Alkan, E. Tuncay, A. Gencoglu, G. Ortakoylu, A. Bahadir, E. Caglar (Yedikule, Istanbul, Turkey). When to give corticosteroid inhalation therapy in stable COPD. Eur Respir J 2001; 16: Suppl. 31, 547
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004
ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004
Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Adherence of stable COPD patients to inhaled pharmacotherapy
Source: Annual Congress 2011 - COPD management
Year: 2011
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006
Adding slow-released theophyllne to inhaled corticosteroids in the treatment of mild persistent asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007
Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate-severe persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Inhaled corticosteroid therapy on admission of hospitalized patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 243s
Year: 2002
Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004
The role of nebulised budesonide in the treatment of exacerbations of COPD
Source: Eur Respir J 2007; 29: 660-667
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept